论文部分内容阅读
Aim: To compare the effect of brimonidine and timolol in reducing visual field loss in acute primary angle closure (APAC) patients. Methods: In addition to standard medical treatment, A-PAC patients were randomised to brimonidine 0.2% or timolol 0.5% at presentation, then twice daily for one month. After laser iridotomy, subjects underwent baseline perimetry during the first
Aim: To compare the effect of brimonidine and timolol in reducing visual field loss in acute primary angle closure (APAC) patients. Methods: In addition to standard medical treatment, A-PAC patients were randomized to brimonidine 0.2% or timolol 0.5% at presentation , then twice daily for one month. After laser iridotomy, subjects underwent baseline perimetry during the first